Opalgenix Inc.
Baden, PA
- UEI
- QSL8FWMH1ZT6
- CAGE
- 8PA95
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 3020 Allman Pl, Baden, PA 15005, USA
- Website
- opalgenix.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Similar vendors
About the company
Opalgenix Inc. is a minority-owned, for-profit corporation that provides genotype-guided physician decision support software and services. Through federal grants, Opalgenix develops pharmacogenetic testing panels, personalized medicine algorithms, and integrates predictive tools into electronic health records to improve clinical outcomes for pain management and substance use disorder treatment.
Opalgenix has received over $2.7 million in National Institutes of Health project grants to develop and clinically validate GPS-Analgesics and GPS-Opioid, 510(k)-cleared predictive analytic software programs incorporating polygenic risk scores, clinical algorithms, and EHR integration. Awards supported prospective studies validating genetic markers for surgical pain and opioid responses, building machine learning models integrating genomic, clinical, and demographic data, and conducting comparative clinical trials against standard of care. Opalgenix also received a Phase I STTR grant from NIDA to develop a laboratory-developed pharmacogenetic test identifying patients at risk for adverse opioid effects after surgery, aiming to prevent outcomes like respiratory depression and neonatal opioid withdrawal syndrome. Partners have included University of Pittsburgh Medical Center and academic researchers under complementary NIH R01 awards. Deliverables have included gene panels, risk quantification algorithms, minimum viable product software prototypes, and comparative clinical trial data.
Quick answers
Is Opalgenix Inc. registered in SAM.gov?
Yes. Opalgenix Inc.'s SAM.gov registration is active through March 30, 2027.
What is Opalgenix Inc.'s most recent federal award?
Opalgenix Inc.'s most recent federal grant award is Improving analgesic effectiveness and safety with proactive precision pain management in thoracic surgical patients… (R43HL167661), from National Heart Lung and Blood Institute (NIH), on August 1, 2023.
On GovTribe
See Opalgenix Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors